Loading quotes...
Forecast
The analysts' average price target is €427.96 (+16.67%). The median is €447.33 (+21.95%).
| Buy |
43 |
| Hold |
7 |
| Sell |
2 |
News Go to news feed
UnitedHealth raises outlook after strong quarter and breaks 50-day line
UnitedHealth exceeded adjusted earnings expectations with $4.69 per share (expectation $4.12) and raised its full-year forecast to at least $20.50 per share. Revenue was $112.7 billion and net income rose to $4.11 billion versus $2.35 billion a year earlier. The stock rose intraday by over three percent and surpassed the 50-day line at $386.06; analysts see on average more than 21% upside and predominantly recommend buy. » More on deraktionaer.de
UnitedHealth raises annual forecast after much stronger quarterly results
UnitedHealth beat earnings expectations in the third quarter with adjusted EPS of $4.69 and raised its 2026 annual forecast to at least $20.50. Revenue fell slightly, but profitability and operating margin improved thanks to lower medical costs, better cost management, and a favorable reserve development. Optum contributed with higher operating results, while membership — particularly in Medicare Advantage — declined, posing a risk to the sustainability of margins. » More on finanzen.net
UnitedHealth bets on a turnaround with "shrink-to-grow" despite cost, investigation and management crises
UnitedHealth, under new management led by Stephen Hemsley, aims to cut operating expenses and the medical loss ratio and is pursuing a "shrink-to-grow" strategy that may depress revenue and member counts in the short term. The company remains under pressure from rising treatment volumes, probes into billing practices, a cyberattack and the death of CEO Brian Thompson. Analysts expect Q3 revenue declines but an adjusted EPS of about $4.14; steady Medicare star ratings are seen as a positive sign of business resilience. Investors will mainly watch progress on the turnaround and balance-sheet strengthening. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 99.49B | 3.18% |
| Gross profit | 19.43B | 10.47% |
| Net profit | 3.63B | 81.35% |
| EBITDA | 6.67B | 46.92% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €335.74B |
Number of shares | 897.6M |
52-week high/low | €412.99 - €229.01 |
Dividend yield | 2.11% |
Dividends TTM | €7.86 |
Beta | 0.62 |
P/E ratio | 23.86 |
PEG ratio | -2.67 |
P/B ratio | 3.62 |
P/S ratio | 0.83 |
Company profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
| Name | UnitedHealth |
| CEO | Stephen J. Hemsley |
| Headquarters | Eden Prairie,
mn USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 10/17/1984 |
| Employees | 390,000 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | UNH |
XETRA | UNH.DE |
Frankfurt | UNH.F |
Düsseldorf | UNH.DU |
Hamburg | UNH.HM |
Milan | 1UNH.MI |
London | 0R0O.L |
SIX | UNH.SW |
München | UNH.MU |
Wien | UNH.VI |